Drugs - HealthQuill

Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US regulatory body placed the experiments on full clinical hold, according to a company statement.

Gilead Sciences puts last-stage blood cancer trials on hold after FDA order

HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US.

by HealthQuill
February 8, 2024
0 Comments

FDA has granted full approval for Janssen Biotech’s Balversa drug to treat metastatic bladder cancer after clinical trials showed “significant” improvement in overall survival rates.

Drugs Health Medical

Global cancer cases set to surge by 77% by 2050, new report warns

HQ Team February 6, 2024: A projection from the Global Cancer Observatory suggests that new cancer cases worldwide are set to surge by.

by HealthQuill
February 6, 2024
0 Comments

Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.

Drugs Medical Pharma

‘Pharma firms manipulate patents to curb competition and drive prices’

A study conducted by researchers from Harvard University has revealed a concerning trend within the pharmaceutical industry— the widespread adoption of intricate patent.

by HealthQuill
February 6, 2024
0 Comments

Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss firm access to a key drug for treating blood cancer.

Drugs Health Pharma

Novartis to buy MorphoSys for $2.9 billion to expand cancer portfolio

HQ Team February 6, 2024: Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss.

by HealthQuill
February 6, 2024
0 Comments

Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.

Drugs Health Medical

Oral insulin successfully tested on animals, human trials set for 2025

Bharti Jayshankar February 5, 2024: Scientists have developed a form of oral insulin, offering an alternative to traditional syringes or insulin pumps. The.

by HealthQuill
February 5, 2024
1 Comment

Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5 billion plant in Germany to make devices for treating diabetes and obesity.

Drugs Health Pharma

Novo Nordisk buys 3 Catalent sites for $11bn to meet rising demand for Wegovy

HQ Team February 5, 2024: Novo Nordisk will acquire three manufacturing sites in an $11bn deal to expand its production of weightless drugs.

by HealthQuill
February 5, 2024
0 Comments

Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease between January-October 2023 period, according to the WHO.

Drugs Health Pharma

Measles spreading rapidly across Europe, WHO calls for urgent curbs

HQ Team February 4, 2024: Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease.

by HealthQuill
February 4, 2024
0 Comments

Drugs Health Medical

Adolescent stress alters brain gene expression, leading to behavioral issues

HQ Team February 3, 2024: New research from the University of São Paulo’s Ribeirão Preto Medical School suggests that excessive stress during adolescence.

by HealthQuill
February 3, 2024
0 Comments

Drugs Health Medical

Polycystic ovary syndrome linked to cognitive issues in women: Study

Bharti Jayshankar February 3, 2024: In a recent study published in the journal Neurology, researchers have uncovered a potential association between polycystic ovary.